Beyond BMD: Understanding Bone Structure
Two treatment groups in a preclinical study may show similar longitudinal bone
mineral density (BMD) trends on DEXA while developing different bone architectures. The density measurements alone may not capture those structural differences.
Bone mechanical properties depend on more than mineral content and can also be influenced by bone architecture, including trabecular organization, thickness, separation, and connectivity. Bone density alone does not tell the whole story, two groups can show similar BMD trends but still develop very different bone structures.
This raises a different research question: not just how much bone mineral has accumulated, but how that bone is structured.
What DEXA Measures and Its Structural Blind Spot
Dual-energy X-ray absorptiometry (DEXA, also commonly written DXA) is an established method for assessing bone mineral density. It is widely used clinically for bone-density assessment and is also used in preclinical research. DEXA systems are also used in small-animal research to measure areal bone mineral density (aBMD) and to monitor changes over time.
DEXA produces a two-dimensional projection from which areal bone mineral density is calculated, rather than a three-dimensional volumetric representation of bone. As a result, it measures bone mineral mass over an area rather than volume.
That means DEXA:
- Does not directly provide the same compartment-specific structural information as Micro-CT. Cortical and trabecular compartments distinguished independently in a projected aBMD measurement.
- Does not provide high-resolution three-dimensional visualization of trabecular microarchitecture. It therefore cannot provide the same direct visualization and morphometric assessment of individual trabeculae, spacing, and connectivity available from high-resolution Micro-CT.
- Reports areal rather than volumetric density. Because aBMD is calculated from mineral content relative to projected area, measurements can be influenced by bone size and geometry.
This doesn’t make DEXA any less valuable in research. It remains a well-established method for tracking changes in aBMD over time. The limitation is that density alone doesn’t tell you how the bone is structured. If the research question focuses on three-dimensional bone architecture, a volumetric imaging method such as Micro-CT can provide complementary information.
What Micro-CT Adds: True 3D Structure at the Microscale
Ex vivo micro-computed tomography (Micro-CT) takes a different approach, acquiring multiple X-ray projections as the specimen rotates and reconstructing them into a three-dimensional volume. The resulting three-dimensional reconstruction can, depending on system configuration, specimen size, and acquisition parameters, provide the spatial resolution needed to assess trabecular microarchitecture.
That 3D view allows researchers to quantify structural features that are not available from a conventional aBMD measurement, including:
- Bone volume fraction (BV/TV): How much of a given volume is made up of bone.
- Trabecular thickness and separation: The thickness of individual struts and the space between them.
- Trabecular number and connectivity: How many trabeculae are present and how well they connect to one another.
- Cortical and trabecular bone separately: With appropriate segmentation and region-of-interest selection, cortical and trabecular compartments can be analyzed independently.
These measurements can help researchers investigate several common preclinical research questions:
- BV/TV and trabecular connectivity can be used as structural endpoints in preclinical studies evaluating changes in bone following treatment.
- Trabecular thickness and separation can be evaluated in preclinical fracture-healing and bone-regeneration studies as measures of bone microarchitecture.
- Separate analysis of cortical and trabecular compartments can provide additional information about bone morphology in studies involving implants, where aBMD alone may not capture local structural changes.
Micro-CT can also support three-dimensional visualization, volumetric rendering, and multiplanar or virtual sectioning of the reconstructed volume—capabilities that are not provided by conventional DEXA imaging.
Additionally, micro-CT can provide calibrated mineral-density measurements in appropriate protocols, although density measurements require suitable calibration and careful consideration of acquisition and reconstruction effects.
Micro-CT vs. DEXA at a Glance: Comparison Table
| DEXA | Micro-CT | |
|---|---|---|
| Data dimensionality | 2D projection / areal measurement | 3D volumetric reconstruction |
| Compartment analysis | Limited compartment-specific structural information from aBMD | Cortical and trabecular bone analyzed independently with appropriate segmentation and ROI selection |
| Typical resolution | Lower spatial resolution; areal measurement | High spatial resolution; suitable for trabecular microarchitecture depending on system/protocol |
| Typical setting | Clinical (human) and preclinical (small-animal), in vivo | Preclinical; in vivo or ex vivo depending on system, specimen and protocol |
| Radiation dose | Generally low-dose; suitable for longitudinal measurements depending on system/protocol | Dose varies with system and acquisition parameters; dose and acquisition time depend strongly on system configuration, resolution, field of view, and acquisition protocol; radiation exposure should be considered carefully for longitudinal in vivo studies. |
| Best suited to | Longitudinal monitoring of aBMD and body composition where applicable | Three-dimensional structural morphometry and high-resolution preclinical research |
DEXA provides an areal measure of bone mineral density, while Micro-CT can provide three-dimensional information about bone architecture and microstructure. The two approaches can therefore answer different, complementary research questions.
Micro-CT vs. DEXA: Matching the Tool to the Research Question
DEXA tends to fit best when:
- The goal is longitudinal monitoring of bone mineral density or body composition in the same living subjects over a study timeline
- Repeated measurements and longitudinal study design are priorities, with dose considered as part of the overall study protocol
- A standardized aBMD measurement is an appropriate endpoint for tracking density changes over time or comparing treatment groups
Micro-CT tends to fit best when:
- The research question concerns three-dimensional trabecular microarchitecture, connectivity, or cortical and trabecular morphology rather than an areal density measurement
- Small-animal preclinical models require high-resolution structural endpoints to characterize bone morphology or microarchitecture
- Ex vivo specimens are being evaluated and acquisition time or radiation exposure can be accommodated within the study protocol
- Researchers need volumetric visualization, virtual sectioning, or three-dimensional morphometric parameters that are not available from a conventional 2D projection
Why Translational Research Often Uses Both
DEXA and Micro-CT can be used sequentially within a preclinical bone research workflow, with each modality addressing different imaging endpoints. Longitudinal DEXA scans can track BMD changes in living subjects over the course of a study; terminal or ex vivo Micro-CT can then provide additional information about trabecular architecture, cortical geometry, and connectivity. In a spinal fusion study, for example, longitudinal DEXA measurements could be used to monitor changes in bone mineral density, while endpoint Micro-CT could provide three-dimensional information about fusion mass morphology, bridging, and the relationship between bone and implant hardware, depending on the study design and imaging protocol.
Longitudinal imaging approaches can also contribute to study designs that consider the principles of Replacement, Reduction, and Refinement (3Rs). Because DEXA can be performed longitudinally in living subjects, researchers may be able to collect repeated measurements from the same animals over the course of a study, depending on the study design and imaging protocol. In some study designs, repeated measurements in the same animals may reduce the need for separate animals at each time point, while endpoint Micro-CT can provide additional structural information.
Beyond Bone: Where Phase-Contrast Micro-CT Can Add Soft-Tissue Information
DEXA is mainly used to measure bone density and body composition. Depending on imaging configuration and acquisition technique, including phase-contrast approaches, Micro-CT can provide additional contrast for lower-density structures such as cartilage and other soft tissues. Applications involving structures such as blood vessels depend on the imaging protocol and specimen.
Showcase: How inCiTe™ Supports High-Resolution Bone and Tissue Research
KA Imaging’s inCiTe™ 3D X-ray Microscope is a benchtop Micro-CT system incorporating propagation-based phase-contrast imaging, which can improve sensitivity to weakly absorbing structures and interfaces while maintaining high-resolution 3D imaging of bone. inCiTe™ 2.0 expands the platform with both phase-contrast and spectral X-ray imaging capabilities, providing additional options for investigating samples containing materials with different X-ray attenuation and spectral characteristics.
inCiTe™ is also available through KA Imaging’s partnership with Scintica Instrumentation, which supplies the iNSiGHT DXA system for preclinical research. Together, the two imaging approaches can be positioned as complementary tools, with DEXA providing longitudinal density measurements and Micro-CT providing additional three-dimensional structural information.
From Density to Structure
Choosing between DEXA and Micro-CT comes down to matching the tool to the research question. DEXA can be used to track bone mineral density over a study timeline, while Micro-CT can provide three-dimensional structural information that an areal density measurement does not capture. Depending on the imaging system and acquisition approach, Micro-CT can also provide additional information about lower-density tissues.
For many translational programs, the most complete picture comes from using both.
To learn more about inCiTe™ and its applications in preclinical research, contact us for more information.